Pharmacy Council Act 2015Section 2
2. Interpretation
In this Act –
“Chairperson” means the Chairperson of the Council;
“Code of Practice” means such Code of Practice as may be prescribed
under section 45;
“committee” means a committee set up under section 10;
318 Acts 2015
“Council” means the Pharmacy Council of Mauritius established
under section 3;
“delegated power” means the powers delegated, under section
89(2)(b)(i) of the Constitution, and subject to Part IVA of the Public
Service Commission Regulations, to the Council by the Public
Service Commission to enquire and report into any complaint of
professional misconduct or negligence against a pharmacist
appointed by the Public Service Commission;
“financial year” has the same meaning as in section 2A of the Finance
and Audit Act;
“foreign pharmacist” means a person registered as such under
section 24;
“licensed auditor” has the same meaning as in the Financial
Reporting Act;
“member” –
(a) means a member of the Council; and
(b) includes the Chairperson;
“Minister” means the Minister to whom responsibility for the subject
of health is assigned;
“officer” –
(a) means a person appointed as such under section 14; and
(b) includes the Registrar;
“pharmaceutical product” has the same meaning as in the Pharmacy
Act;
“pharmacist” means a person registered as such under section 18;
“Pharmacy Board” means the Pharmacy Board established under the
Pharmacy Act;
Acts 2015 319
“pharmacy dispenser” means a person who is a dispenser of
pharmaceutical products or assists a pharmacist in dispensing
pharmaceutical products;
“practice of pharmacy” includes –
(a) dispensing, compounding, labelling, manufacturing,
distributing, administering and preserving pharmaceutical
products;
(b) interpreting prescriptions;
(c) patient counselling for the purposes of dispensing
pharmaceutical products;
(d) evaluating the use of pharmaceutical products;
(e) manufacturing and distributing pharmaceutical products;
(f) quality assurance at each level of pharmacy operation;
(g) research and development of pharmaceutical products;
(h) reporting adverse drug reactions (ADR) through the
established mechanism of the pharmacovigilance unit of the
Ministry;
“preliminary investigation” means a preliminary investigation under
section 27;
“pre-registration trainee” means a person registered as such under
section 22;
“Register” means the register of pharmacists, kept under section 21;
“registered nurse” has the same meaning as in the Nursing Council
Act;
“Registrar” means the Registrar of the Council appointed under
section 12;
“resident” has the same meaning as in the Immigration Act;
“supervising officer” means the supervising officer of the Ministry;
320 Acts 2015
“Tribunal” means the Medical Disciplinary Tribunal set up under the
Medical Council Act;
“Vice-chairperson” means the Vice-chairperson of the Council;
“visiting pharmacist” means a person registered as such under
section 25.
PART II – THE COUNCIL